Teleflex Incorporated
General ticker "TFX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $6.3B (TTM average)
Teleflex Incorporated does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 2.0%: low 126.05$, high 131.02$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-03-06, amount 0.34$ (Y1.03%)
- Total employees count: 14100 (-2.8%) as of 2024
- US accounted for 62.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Market risk, ERP system disruptions, Sterilization issues
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [96.82$, 153.20$]
- 2026-12-31 to 2027-12-31 estimated range: [99.14$, 156.33$]
Financial Metrics affecting the TFX estimates:
- Negative: with PPE of 10.0 at the end of fiscal year the price was high
- Positive: 7.68 < Operating profit margin, % of 12.84
- Positive: -3.36 < Return on assets ratio (scaled to [-100,100]) of 0.84
- Positive: 42.60 < Shareholder equity ratio, % of 44.98 <= 64.25
- Positive: -8.75 < Industry operating profit margin (median), % of -1.25
- Positive: 0.07 < Operating cash flow per share per price, % of 6.21
- Negative: Industry operating cash flow per share per price (median), % of 2.91 <= 5.46
Short-term TFX quotes
Long-term TFX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,933.69MM | $2,914.59MM | $1,992.71MM |
| Operating Expenses | $2,427.38MM | $2,763.58MM | $1,736.91MM |
| Operating Income | $506.31MM | $151.01MM | $255.80MM |
| Non-Operating Income | $-72.30MM | $-75.53MM | $-231.25MM |
| Interest Expense | $85.08MM | $83.54MM | $100.22MM |
| R&D Expense | $154.35MM | $161.67MM | $144.78MM |
| Income(Loss) | $434.01MM | $75.48MM | $24.55MM |
| Taxes | $76.44MM | $5.32MM | $-33.98MM |
| Other Income(Loss) | $-1.24MM | $-0.49MM | $0.00MM |
| Profit(Loss)* | $355.08MM | $69.19MM | $-905.64MM |
| Stockholders Equity | $4,440.99MM | $4,278.14MM | $3,124.77MM |
| Inventory | $626.22MM | $600.13MM | $404.39MM |
| Assets | $7,532.55MM | $7,097.91MM | $6,947.24MM |
| Operating Cash Flow | $510.64MM | $635.74MM | $340.68MM |
| Capital expenditure | $91.44MM | $126.43MM | $95.24MM |
| Investing Cash Flow | $-621.23MM | $-99.36MM | $-849.19MM |
| Financing Cash Flow | $38.54MM | $-421.93MM | $611.54MM |
| Earnings Per Share** | $7.56 | $1.48 | $-20.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.